Phong Phu Pharmaceutical JSC (HNX:PPP)

Market Cap	183.04B
Revenue (ttm)	135.89B
Net Income (ttm)	17.17B
Shares Out	8.80M
EPS (ttm)	1,948.42
PE Ratio	10.68
Forward PE	n/a
Dividend	1,500.00 (7.54%)
Ex-Dividend Date	Mar 21, 2025

Volume	411
Average Volume	1,032
Open	20,000
Previous Close	19,900
Day's Range	20,000 - 21,800
52-Week Range	15,700 - 23,100
Beta	0.08
RSI	50.58
Earnings Date	Oct 23, 2025

About HNX:PPP

Phong Phu Pharmaceutical Joint Stock Company engages in the production, sale, and distribution of medicines primarily in Vietnam. The company’s medicines are derived from medicinal herbs, pharmaceutical chemicals, and health protection food, that are offered in tablets, film-coated, sugar-coated, soft capsules, granules, powder, and other forms. It offers its products for respiratory, spiritual, anti-inflammatory, anti-allergic, digest, cardiovascular, diabetes, liver function, and osteoarthritis, as well as provides vitamins and minerals. The ...

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 212
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: PPP

Financial Performance

In 2024, HNX:PPP's revenue was 137.55 billion, a decrease of -9.61% compared to the previous year's 152.17 billion. Earnings were 15.55 billion, a decrease of -14.28%.